Our findings that GN25 modulated neutrophils and T-cells tumor responses may result from the combination of p53 activation and Snail inhibition and suggest that GN25 might be as effective as combined treatment with p53 activators and Snail inhibitors in NSCLC. The gene discussed is TP53; the disease is neoplasm.